Merck, with a heavy presence in physician-administered drugs, predicts a $2.1B sales hit from COVID-19

Regeneron CEO, R&D chief take 20% pay cuts in year marked by Eylea threats, Sanofi rejig

AI could serve as backup to radiologists’ eyes

Relieving Parkinson’s disease symptoms with light-based deep brain stimulation

Covid-19: concerns grow over inflammatory syndrome emerging in children

Covid-19: NHS will restart some paused services this week

Helen Salisbury: No time for decision making

Risks to children and young people during covid-19 pandemic

Covid-19: undocumented migrants are probably at greatest risk

ViiV unveils £3m fund to study impact of COVID19 on HIV community